FI65066C - Foerfarande foer framstaellning av nya terapeutiskt verksamma 2-merkaptoimidazolderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt verksamma 2-merkaptoimidazolderivat Download PDF

Info

Publication number
FI65066C
FI65066C FI791158A FI791158A FI65066C FI 65066 C FI65066 C FI 65066C FI 791158 A FI791158 A FI 791158A FI 791158 A FI791158 A FI 791158A FI 65066 C FI65066 C FI 65066C
Authority
FI
Finland
Prior art keywords
tai
formula
phenyl
tarkoittaa
pyridyl
Prior art date
Application number
FI791158A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI791158A (fi
FI65066B (fi
Inventor
Pier Giorgio Ferrini
Richard Goeschke
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI791158A publication Critical patent/FI791158A/fi
Publication of FI65066B publication Critical patent/FI65066B/fi
Application granted granted Critical
Publication of FI65066C publication Critical patent/FI65066C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI791158A 1978-04-11 1979-04-09 Foerfarande foer framstaellning av nya terapeutiskt verksamma 2-merkaptoimidazolderivat FI65066C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU79412 1978-04-11
LU79412 1978-04-11

Publications (3)

Publication Number Publication Date
FI791158A FI791158A (fi) 1979-10-12
FI65066B FI65066B (fi) 1983-11-30
FI65066C true FI65066C (fi) 1984-03-12

Family

ID=19728887

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791158A FI65066C (fi) 1978-04-11 1979-04-09 Foerfarande foer framstaellning av nya terapeutiskt verksamma 2-merkaptoimidazolderivat

Country Status (24)

Country Link
US (3) US4461770A (fr)
EP (1) EP0004648B1 (fr)
JP (1) JPS54135769A (fr)
KR (2) KR820002314B1 (fr)
AT (1) AT376971B (fr)
AU (1) AU532402B2 (fr)
CS (1) CS220324B2 (fr)
CY (1) CY1302A (fr)
DD (1) DD142712A5 (fr)
DE (1) DE2963572D1 (fr)
DK (1) DK148879A (fr)
ES (5) ES479490A0 (fr)
FI (1) FI65066C (fr)
GR (1) GR71193B (fr)
HK (1) HK87285A (fr)
HU (1) HU182018B (fr)
IL (1) IL57040A (fr)
MY (1) MY8600271A (fr)
NO (1) NO148926C (fr)
NZ (1) NZ190153A (fr)
PL (2) PL125972B1 (fr)
PT (1) PT69460A (fr)
SU (2) SU1259962A3 (fr)
ZA (1) ZA791702B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5955480A (en) * 1996-11-20 1999-09-21 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
HUP0002842A3 (en) * 1997-04-24 2002-01-28 Ortho Mcneil Pharm Inc Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates
CA2295021A1 (fr) * 1997-06-30 1999-01-28 Ortho-Mcneil Pharmaceutical, Inc. Imidazoles substituees en 2 utilisables pour le traitement de maladies inflammatoires
DE19842833B4 (de) 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) * 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
CA2614282A1 (fr) 2005-07-06 2007-01-11 Sepracor Inc. Combinaisons d'eszopiclone et de trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphtalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphtalenamine, et methodes de traitement de la menopause et des troubles de l'humeur, de l'anxiete et troubles cognitifs
EP2816024B8 (fr) * 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Amines chiraux
EP1894925A1 (fr) * 2006-08-24 2008-03-05 Merckle Gmbh Derivés d'imidazole ayant une activité anti-inflammatoire

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
US3714179A (en) * 1970-09-08 1973-01-30 Searle & Co 1-alkyl-2-furfurylthioimidazoles and congeners
JPS5343958B2 (fr) * 1972-07-29 1978-11-24
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4308277A (en) * 1978-08-10 1981-12-29 Ciba-Geigy Corporation 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
US4584310A (en) 1986-04-22
EP0004648B1 (fr) 1982-08-25
NO148926C (no) 1984-01-11
ES8504737A1 (es) 1985-05-01
EP0004648A3 (en) 1979-11-14
NZ190153A (en) 1981-05-15
EP0004648A2 (fr) 1979-10-17
AU532402B2 (en) 1983-09-29
DK148879A (da) 1979-10-12
IL57040A0 (en) 1979-07-25
ES8303355A1 (es) 1983-02-01
PL125972B1 (en) 1983-06-30
SU1259962A3 (ru) 1986-09-23
JPS6339594B2 (fr) 1988-08-05
PL214745A1 (fr) 1980-06-16
DE2963572D1 (en) 1982-10-21
ES8403877A1 (es) 1984-04-01
KR820002315B1 (ko) 1982-12-17
IL57040A (en) 1984-08-31
DD142712A5 (de) 1980-07-09
FI791158A (fi) 1979-10-12
NO148926B (no) 1983-10-03
SU991945A3 (ru) 1983-01-23
HK87285A (en) 1985-11-15
KR820002314B1 (ko) 1982-12-17
PT69460A (en) 1979-05-01
ES8505352A1 (es) 1985-05-16
NO791228L (no) 1979-10-12
ES515766A0 (es) 1984-04-01
ATA266179A (de) 1984-06-15
HU182018B (en) 1983-12-28
ES528580A0 (es) 1985-05-01
CS220324B2 (en) 1983-03-25
ES479490A0 (es) 1983-02-01
JPS54135769A (en) 1979-10-22
FI65066B (fi) 1983-11-30
CY1302A (en) 1985-12-06
ES528581A0 (es) 1985-05-16
ES8504738A1 (es) 1985-05-01
AT376971B (de) 1985-01-25
PL125882B1 (en) 1983-06-30
ZA791702B (en) 1980-04-30
GR71193B (fr) 1983-04-11
AU4599479A (en) 1979-10-18
MY8600271A (en) 1986-12-31
US4461770A (en) 1984-07-24
ES528579A0 (es) 1985-05-01
US4608382A (en) 1986-08-26

Similar Documents

Publication Publication Date Title
FI65066C (fi) Foerfarande foer framstaellning av nya terapeutiskt verksamma 2-merkaptoimidazolderivat
US20070072911A1 (en) Indoles and azaindoles as antiviral agents
EP0040696B1 (fr) Aminothiadiazoles comme inhibiteurs de la sécrétion gastrique
RU2086542C1 (ru) Серосодержащие производные имидазола, способ их получения, новые промежуточные соединения и фармацевтическая композиция
Ashton et al. Nonpeptide angiotensin II antagonists derived from 4H-1, 2, 4-triazoles and 3H-imidazo [1, 2-b][1, 2, 4] triazoles
GB2163747A (en) Benzimidazole derivatives
SK110096A3 (en) Arylalkyldiazinon derivative, preparation method thereof and pharmaceutical composition containing same
FI76797B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara tiadiazinon-, oxadiazinon- och triazinonderivat.
CA2137976A1 (fr) Derives de thienothiazine
US5891895A (en) Hydroxypyridine derivatives their production and use
JPS6157587A (ja) 縮合複素環誘導体および抗潰瘍剤
RU2024522C1 (ru) Производные дипиридо-диазепина и их фармакологически переносимые соли, обладающие биологической активностью
AU702609B2 (en) Pyridylthio compounds for controlling helicobacter bacteria
EP0270091B1 (fr) Dérivés de l'imidazole, leurs procédés de préparation, compositions pharmaceutiques les contenant, leur utilisation pour la production de médicaments utiles en thérapeutiques et produits intermédiaires formés dans lesdits procédés
KR100373968B1 (ko) 사치환이미다졸유도체,그의제조방법,그에대한중간화합물,의약으로서의그의용도및그를함유하는제약조성물
SK123199A3 (en) Process for preparing pyrazole derivatives
Al‐Saleh et al. N‐Azolylmethyl ketones as building blocks in heterocyclic synthesis: Synthesis of new polyfunctionally substituted azolylarylazophenols, azolylpyridones and azolylthiophenes
FI69462B (fi) Foerfarande foer framstaellning av inflammationsmotverkande 4,-diaryl-2-(substituerad tio sulfinyl eller sulfonyl)imida zoderivat
EP0579059A1 (fr) Dérivés de pyridazinone et procédé de préparation
CS250248B2 (en) Method of imidazole's tricyclic derivatives production
US3991191A (en) Antiprotozoal (1-alkyl-5-nitro-imidazolyl-2-alkyl)-pyrimidines
US4179512A (en) 4-Substituted-2-arylimidazoles
US4110456A (en) 4-substituted-2-arylimidazoles
JPS60209573A (ja) １，２，４‐トリアザシクロアルカジエン誘導体、該誘導体を含む医薬製剤及び該誘導体の製造方法
CA1180712A (fr) Derives de mercapto-imidazole

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CIBA-GEIGY AG